Agus A, Clement K, Sokol H (2021) Gut microbiota-derived metabolites as central regulators in metabolic disorders. Gut 70:1174–1182. https://doi.org/10.1136/gutjnl-2020-323071

Article  CAS  PubMed  Google Scholar 

Ahmad TR, Haeusler RA (2019) Bile acids in glucose metabolism and insulin signalling - mechanisms and research needs. Nat Rev Endocrinol 15:701–712. https://doi.org/10.1038/s41574-019-0266-7

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bokulich NA, Kaehler BD, Rideout JR, Dillon M, Bolyen E, Knight R, Huttley GA, Gregory Caporaso J (2018) Optimizing taxonomic classification of marker-gene amplicon sequences with QIIME 2’s q2-feature-classifier plugin. Microbiome 6:90. https://doi.org/10.1186/s40168-018-0470-z

Article  PubMed  PubMed Central  Google Scholar 

Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJ, Holmes SP (2016) DADA2: high-resolution sample inference from Illumina amplicon data. Nat Methods 13:581–583. https://doi.org/10.1038/nmeth.3869

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cani PD, Van Hul M, Lefort C, Depommier C, Rastelli M, Everard A (2019) Microbial regulation of organismal energy homeostasis. Nat Metab 1:34–46. https://doi.org/10.1038/s42255-018-0017-4

Article  CAS  PubMed  Google Scholar 

Chen Y, Zhou J, Wang L (2021) Role and mechanism of Gut Microbiota in Human Disease. Front Cell Infect Microbiol 11:625913. https://doi.org/10.3389/fcimb.2021.625913

Article  CAS  PubMed  PubMed Central  Google Scholar 

De Vadder F, Kovatcheva-Datchary P, Goncalves D, Vinera J, Zitoun C, Duchampt A, Bäckhed F, Mithieux G (2014) Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell 156:84–96. https://doi.org/10.1016/j.cell.2013.12.016

Article  CAS  PubMed  Google Scholar 

de Vos WM, Tilg H, Van Hul M, Cani PD (2022) Gut microbiome and health: mechanistic insights. Gut 71:1020–1032. https://doi.org/10.1136/gutjnl-2021-326789

Article  CAS  PubMed  Google Scholar 

Deng L, Yang Y, Xu G (2022) Empagliflozin ameliorates type 2 diabetes mellitus-related diabetic nephropathy via altering the gut microbiota. Biochim Biophys Acta Mol Cell Biol Lipids 1867:159234. https://doi.org/10.1016/j.bbalip.2022.159234

Article  CAS  PubMed  Google Scholar 

Esgalhado M, Kemp JA, Damasceno NR, Fouque D, Mafra D (2017) Short-chain fatty acids: a link between prebiotics and microbiota in chronic kidney disease. Future Microbiol 12:1413–1425. https://doi.org/10.2217/fmb-2017-0059

Article  CAS  PubMed  Google Scholar 

Fan Y, Pedersen O (2021) Gut microbiota in human metabolic health and disease. Nat Rev Microbiol 19:55–71. https://doi.org/10.1038/s41579-020-0433-9

Article  CAS  PubMed  Google Scholar 

Ferrannini E, Ramos SJ, Salsali A, Tang W, List JF (2010) Dapagliflozin monotherapy in type 2 diabetic patients with inadequate glycemic control by diet and exercise: a randomized, double-blind, placebo-controlled, phase 3 trial. Diabetes Care 33:2217–2224. https://doi.org/10.2337/dc10-0612

Article  PubMed  PubMed Central  Google Scholar 

Hata S, Okamura T, Kobayashi A, Bamba R, Miyoshi T, Nakajima H, Kitagawa N, Hashimoto Y, Majima S, Senmaru T et al (2022) Gut Microbiota Changes by an SGLT2 Inhibitor, Luseogliflozin, Alters Metabolites Compared with Those in a Low Carbohydrate Diet in db/db Mice. Nutrients. https://doi.org/10.3390/nu14173531

Article  PubMed  PubMed Central  Google Scholar 

Inagaki N, Kondo K, Yoshinari T, Maruyama N, Susuta Y, Kuki H (2013) Efficacy and safety of canagliflozin in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, 12-week study. Diabetes Obes Metab 15:1136–1145. https://doi.org/10.1111/dom.12149

Article  CAS  PubMed  PubMed Central  Google Scholar 

Koh A, De Vadder F, Kovatcheva-Datchary P, Backhed F (2016) From Dietary Fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell 165:1332–1345. https://doi.org/10.1016/j.cell.2016.05.041

Article  CAS  PubMed  Google Scholar 

Kovacs CS, Seshiah V, Swallow R, Jones R, Rattunde H, Woerle HJ, Broedl UC (2014) Empagliflozin improves glycaemic and weight control as add-on therapy to pioglitazone or pioglitazone plus metformin in patients with type 2 diabetes: a 24-week, randomized, placebo-controlled trial. Diabetes Obes Metab 16:147–158. https://doi.org/10.1111/dom.12188

Article  CAS  PubMed  Google Scholar 

Leonhardt J, Haider RS, Sponholz C, Leonhardt S, Drube J, Spengler K, Mihaylov D, Neugebauer S, Kiehntopf M, Lambert NA et al (2021) Circulating bile acids in liver failure activate TGR5 and induce Monocyte Dysfunction. Cell Mol Gastroenterol Hepatol 12:25–40. https://doi.org/10.1016/j.jcmgh.2021.01.011

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li YJ, Chen X, Kwan TK, Loh YW, Singer J, Liu Y, Ma J, Tan J, Macia L, Mackay CR et al (2020) Dietary Fiber protects against Diabetic Nephropathy through short-chain fatty acid-mediated activation of G protein-coupled receptors GPR43 and GPR109A. J Am Soc Nephrol 31:1267–1281. https://doi.org/10.1681/asn.2019101029

Article  CAS  PubMed  PubMed Central  Google Scholar 

Marion S, Desharnais L, Studer N, Dong Y, Notter MD, Poudel S, Menin L, Janowczyk A, Hettich RL, Hapfelmeier S et al (2020) Biogeography of microbial bile acid transformations along the murine gut. J Lipid Res 61:1450–1463. https://doi.org/10.1194/jlr.RA120001021

Article  CAS  PubMed  PubMed Central  Google Scholar 

Marron MM, Orwoll ES, Cawthon PM, Lane NE, Newman AB, Cauley JA (2022) Oxylipins Associated with D3-Creatine Muscle Mass/Weight and Physical Performance among Community-Dwelling Older Men. Int J Mol Sci. https://doi.org/10.3390/ijms232112857

Article  PubMed  PubMed Central  Google Scholar 

Martin POS, Lawley JC, Browne TD, Harris HP, Bernalier-Donadille HMB, Duncan A, O’Toole SH PW, K PS, H JF (2016) Polysaccharide utilization loci and nutritional specialization in a dominant group of butyrate-producing human colonic Firmicutes. Microb Genom 2:e000043. https://doi.org/10.1099/mgen.0.000043

Article  PubMed  PubMed Central  Google Scholar 

McMurray JJV, Solomon SD, Inzucchi SE, Køber L, Kosiborod MN, Martinez FA, Ponikowski P, Sabatine MS, Anand IS, Bělohlávek J et al (2019) Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med 381:1995–2008. https://doi.org/10.1056/NEJMoa1911303

Article  CAS  PubMed  Google Scholar 

Misheva M, Kotzamanis K, Davies LC, Tyrrell VJ, Rodrigues PRS, Benavides GA, Hinz C, Murphy RC, Kennedy P, Taylor PR et al (2022) Oxylipin metabolism is controlled by mitochondrial beta-oxidation during bacterial inflammation. Nat Commun 13:139. https://doi.org/10.1038/s41467-021-27766-8

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Mueller NT, Differding MK, Zhang M, Maruthur NM, Juraschek SP, Miller ER 3rd, Appel LJ, Yeh HC (2021) Metformin affects gut microbiome composition and function and circulating short-chain fatty acids: a Randomized Trial. Diabetes Care 44:1462–1471. https://doi.org/10.2337/dc20-2257

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nayeem MA (2018) Role of oxylipins in cardiovascular diseases. Acta Pharmacol Sin 39:1142–1154. https://doi.org/10.1038/aps.2018.24

Article  CAS  PubMed  PubMed Central  Google Scholar 

Olivares M, Neyrinck AM, Pötgens SA, Beaumont M, Salazar N, Cani PD, Bindels LB, Delzenne NM (2018) The DPP-4 inhibitor vildagliptin impacts the gut microbiota and prevents disruption of intestinal homeostasis induced by a Western diet in mice. Diabetologia 61:1838–1848. https://doi.org/10.1007/s00125-018-4647-6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Packer M, Anker SD, Butler J, Filippatos G, Pocock SJ, Carson P, Januzzi J, Verma S, Tsutsui H, Brueckmann M et al (2020) Cardiovascular and renal outcomes with Empagliflozin in Heart failure. N Engl J Med 383:1413–1424. https://doi.org/10.1056/NEJMoa2022190

Article  CAS  PubMed  Google Scholar 

Pereira FC, Wasmund K, Cobankovic I, Jehmlich N, Herbold CW, Lee KS, Sziranyi B, Vesely C, Decker T, Stocker R et al (2020) Rational design of a microbial consortium of mucosal sugar utilizers reduces Clostridiodes difficile colonization. Nat Commun 11:5104. https://doi.org/10.1038/s41467-020-18928-1

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Perry RJ, Peng L, Barry NA, Cline GW, Zhang D, Cardone RL, Petersen KF, Kibbey RG, Goodman AL, Shulman GI (2016) Acetate mediates a microbiome-brain-β-cell axis to promote metabolic syndrome. Nature 534:213–217. https://doi.org/10.1038/nature18309

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Quast C, Pruesse E, Yilmaz P, Gerken J, Schweer T, Yarza P, Peplies J, Glockner FO (2013) The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res 41:D590–596. https://doi.org/10.1093/nar/gks1219

Article  CAS  PubMed